High-Content Screening for Target Identification and Validation (Technical Insights)

 


This research service covers the High Content Screening Market for Target Identification and Validation.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

High-Content Screening for Target Identification and Validation (Technical Insights), Executive SummaryScope and MethodologyScopeMethodologyKey FindingsIntroductionNoteworthy Emerging Technologies and ApplicationsAssessment of Competing TechnologiesHigh-Content Screening for Target Identification and Validation (Technical Insights), Technology and Applications ViewpointTechnology and Applications AnalysisTechnology PrimerHigh Content Screening Vs. Competing TechnologiesTechnological Developments and Innovations in CompaniescellWorx High Content Screening Analysis System developed by Applied Precision--USA Microarray Platform developed by Metrigenics--USAAcumen Explorer 488 developed by TTP LabTech--USA Redistribution Technology by BioImageTechnology Adoption FactorAnalysis of Technology DriversAnalysis of Technology ChallengesAnalysis of Technology RestraintsFuture Trends; Capital Funding; Partnerships and AlliancesTechnology and Application TrendsCapital Funding AnalysisPartnerships and AlliancesHigh-Content Screening for Target Identification and Validation (Technical Insights), Assessment of Innovations and Opportunities- USATechnological Developments and Innovations in UniversitiesHigh-Throughput Screening of Neuraminidase Inhibitors--USA A Small Molecule that Induces Mitotic Arrest--USA High-Content Screening for Target Identification and Validation (Technical Insights), Assessment of Innovations and Opportunities- Europe and Asia PacificTechnological Developments and Innovations in CompaniesMulticolor Color BiFC Assays Developed by Purdue University--USAElectrochemical High-Content Screening of Nitric Oxide Release from Endothelial Cells--USACellenger- A High Content Screening Instrument developed by Definiens--GermanyHigh-Content Screening Microscopy Identifies Novel Proteins--GermanyPathfinder Technology developed by IMSTARBionas Analyzing SystemTechnological Developments and Innovations in Universities A High-throughput screening of Genes Encoding Proteins--Tokyo High-Content Screening Using a Human Kinase siRNA Library--GermanyHigh-Content Screening for Target Identification and Validation (Technical Insights), Key Patents; Contacts; GlossaryKey PatentsUS Patents; 2006US Patents; 2005Contacts and GlossaryDatabase of Key industry ParticipantsUniversity ParticipantsGlossaryHigh-Content Screening for Target Identification and Validation (Technical Insights), Frost & Sullivan 2006 Science and Technology AwardsProduct Innovation AwardAward DescriptionAward RecipientTechnology Innovation AwardAward DescriptionAward RecipientExcellence in TechnologyAward DescriptionAward RecipientHigh-Content Screening for Target Identification and Validation (Technical Insights), Decision Support DatabaseDatabase TablesTotal Healthcare Expenditure (1999-2006)Pharma R&D Expenditure (1999-2006)Govt Biotech R&D Investment (1999-2006)Private Biotech R&D Investment (1999-2006)




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.